Characterization of women with a history of recurrent vulvovaginal candidosis

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 11, 2002, Pages 1047-1052

  Novikova, Natalia ^a   Mårdh, Per Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

History; Pathogenesis; Recurrent vulvovaginal candidosis; Signs; Symptoms

Indexed keywords

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BURN; CANDIDA; CLINICAL EXAMINATION; DISEASE ASSOCIATION; EDEMA; ERYTHEMA; FEMALE; FUNGUS CULTURE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; SYMPTOMATOLOGY; VAGINA; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VAGINA MUCOSA; VULVA DISEASE;

ADOLESCENT; ADULT; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; RECURRENCE;

EID: 0036849210     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.811109.x     Document Type: Article

References (26)

1. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidlasis. Am J Obstet Gynecol 1985; 152: 924-35.
2. Mårdh P-A, Rodrigues A, Gene M, Novikova N, Martinez-de-Oliveira J, Guashino S. Facts and myths on recurrent vulvovaginal candidosis - A review of epidemiology, pathogenesis, diagnosis and therapy. Int J STD & AIDS 2002; 13: 522-39.
3. Sobel JD. Recurrent vulvovaginal candidiasis. New Engl J Med 1986; 315: 1455-8.
4. Elegbe IA, Elegbe I. Quantitative relationships of Candida albicans infections and dressing patterns in Nigerian women. Am J Public Health 1983; 73: 450-2.
5. Ledger WL. Current problems in the diagnosis and treatment of Candida vaginitis. Ital J Obst Gyn 1999; 11: 25-9.
6. Novikova N, Rodrigues A, Mårdh P-A. Can the diagnosis of recurrent vulvovaginal candidosis be improved by the use of vaginal lavage samples and cultures on chromogenic agar. Inf Dis Obstet Gynecol 2002; (in press).
7. Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes K-K. Vulvovaginal candidiasis: Clinical manifestations, risk factors, management algorithm. Obstet Gynecol 1998; 92: 757-62.
8. Cotch M, Hillier SL, Gibbs RS, Eschenbach DA for the Vaginal Infections Prematurity Study Group. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Am J Obstet Gynecol 1998; 178: 374-80.
9. Hellberg D, Zdolsek B, Nilsson S, Mårdh P-A. Sexual behaviour of women with repeated episodes of vulvovaginal candidlasis. Eur J Epidemiol 1995; 11: 525-9.
10. Fidel PU, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun 2000; 68: 652-7.
11. Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A. The impact of oral contraception on vulvovaginal candidiasis. Contraception 1995; 51: 293-7.
12. Schmidt A, Noldechen CF, Mendling W, Hatzmann W, Wolff MH. Oral contraceptive use and vaginal candida colonization. Zentralbl Gynakol 1997; 119: 545-9.
13. Geiger AM, Foxman B. Risk factors in vulvovaginal candidiasis: A case-control study among college students. Epidemiology 1996; 7: 182-7.
14. Hooton TM, Roberts PL, Stamm WE. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis 1994; 19: 274-8.
15. McGroarty JA, Soboh F, Bruce AW, Reid G. The spermicidal compound nonoxynol-9 increases adhesion of Candida species to human epithelial cell in vitro. Infect Immun 1990; 58: 2005-7.
16. Novikova N, Yassievich E, Mårdh P-A. Microscopy of stained smears of genital secretion in the diagnosis of recurrent vulvovaginal candidosis. Int J STD & AIDS 2002; 13: 318-22.
17. Spinillo A, Carratta L, Pizzoli G, Lombardi G, Cavanna C, Michelone G et al. Recurrent vaginal candidiasis. Results of a cohort study of sexual transmission and intestinal reservoir. J Reprod Med 1992; 37: 343-7.
18. Otero L, Palacio V, Carrero F, Mendez FJ, Vazquez F. Vulvovaginal candidiasis in female sex workers. Int J STD & AIDS 1998; 9: 526-30.
19. Mårdh P-A, Novikova N, Stukalova E. Colonization by Candida of extragenital sites in cases of recurrent vulvovaginal candidosis. Br J Obstet Gynecol 2002; (in press).
20. Rashid S, Collins M, Corner J, Morton RS. Survival of Candida albicans on fabric after laundering. Br Vener Dis 1984; 60: 277.
21. Odds FC. Factors that predispose the host to candidosis. In: Odds FC (ed.): Candida and Candidosis. Baltimore: University Park Press, 1988: 93-114.
22. Goswami R, Dadhwal V, Tejaswi S, Datta K, Paul A, Haricharan RN et al. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status. J Infect 2000; 41: 162-6.
23. Witkin SS, Jerernias J, Ledger WL. Vaginal eosinophils and 1gE antibodies to Candida albicans in women with recurrent vaginitis. J Med Vet Mycol 1989; 27: 57-8.
24. Foxman B. The epidemiology of vulvovaginal candidlasis; risk factors. Am J Public Health 1990; 80: 329-31.
25. Lynch ME, Sobel JD, Fidel PL. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis. J Med Vet Mycol 1996; 34: 337-9.
26. Pina-Vaz C, Sansonetty F, Rodrigues AG, Martinez-de-Oliveira J, Fonseca AF, Mårdh P-A. Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J Med Microbiol 2000; 49: 831-40.